Recent News

• 05.13.2025 - Athira Pharma to Present Data from First-in-Human Phase 1 Clinical Trial of ATH-1105 at the 4th Annual ALS Drug Development Summit
• 05.13.2025 - Athira Pharma to Present Data from First-in-Human Phase 1 Clinical Trial of ATH-1105 at the 4th Annual ALS Drug Development Summit
• 05.09.2025 - Athira Pharma Reports First Quarter 2025 Financial Results and Pipeline and Business Updates
• 05.09.2025 - Athira Pharma Reports First Quarter 2025 Financial Results and Pipeline and Business Updates
• 02.27.2025 - Athira Pharma Reports Full Year 2024 Financial Results and Pipeline and Business Updates

Recent Filings

• 05.09.2025 - 8-K Current report
• 05.09.2025 - EX-99.1 EX-99.1
• 05.09.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 04.16.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 04.16.2025 - 8-K Current report
• 04.14.2025 - DEF 14A Other definitive proxy statements
• 04.14.2025 - ARS Annual Report to Security Holders
• 04.14.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 04.04.2025 - PRE 14A Other preliminary proxy statements
• 03.12.2025 - 4/A Statement of changes in beneficial ownership of securities